(THC) Tenet Healthcare - Ratings and Ratios

Tenet Healthcare Corporation (NYSE: THC) is a major player in the U.S. healthcare sector, operating as a diversified healthcare services company. The firm is structured into two primary segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals provide a wide array of medical services, including acute care, radiology, respiratory therapy, clinical laboratories, and pharmacies. Additionally, they offer specialized care units such as intensive care, coronary care, and cardiovascular services.

The company’s service portfolio extends to tertiary and quaternary care, encompassing advanced procedures like cardiothoracic surgery, neonatal intensive care, and organ transplants. They also provide minimally invasive cardiac valve replacements, robotic surgery, and telemedicine services, showcasing their commitment to both traditional and cutting-edge medical care. Beyond hospitals, Tenet operates ambulatory surgery centers, imaging centers, and micro-hospitals, creating a robust network of healthcare facilities.

Founded in 1967 and headquartered in Dallas, Texas, Tenet Healthcare has established itself as a significant provider of healthcare services. With a market capitalization of $13.358 billion, the company trades on the NYSE under the ticker symbol THC. Its financial metrics, such as a P/E ratio of 4.43 and a forward P/E of 11.75, provide insight into its valuation and investor expectations. The price-to-book ratio of 3.47 and price-to-sales ratio of 0.64 further highlight its financial position in the healthcare sector.